dihexa injectable peptide Dihexa | Rize Up Medical
Description
Intranasal is the validated route
Pregnancy or planned pregnancy Semaglutide is contraindicated in pregnancy
inflammatory bowel syndrome etc
Some of these options will be relatively risk-free and lead to predictable over-par (but not too over-par) outcomes
Common trial endpoints are (1) new gadolinium-enhancing T1-weighted lesions, (2) new or enlarging T2-weighted lesions, (3) annualized relapse rates, and (4) confirmed disability progression for 6 months
What are the next steps needed to advance BPC-157 from preclinical research to human trials
